Breathe Biomedical Expands Clinical Study
Moncton-based Breathe BioMedical has expanded a clinical study of its breast cancer detection device after a clinical study found an 88 percent success rate in detecting breast cancer.
The company issued a press release recently saying that Pittsburgh’s Weinstein Imaging Associates has become the fourth site in its multi-centre observational study aimed at advancing a breath test designed to